![](/img/cover-not-exists.png)
An Improved Benefit-Risk Profile of Duvelisib in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received ≥2 Prior Therapies
Davids, Matthew, Hillmen, Peter, Montillo, Marco, Delgado, Julio, Kuss, Bryone, Tam, Constantine, Jäger, Ulrich, Ghia, Paolo, Stilgenbauer, Stephan, Cymbalista, Florence, Lustgarten, Stephanie, WeaverVolume:
19
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.209
Date:
September, 2019
File:
PDF, 70 KB
english, 2019